Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-28

Clinical Trial Update: Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dietary fish oil intervention in Polycystic Ovary Syndrome to assess effects on lipid metabolism; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil supplement (fish oil)

Snippet

Sponsor: University of Alberta | Conditions: Polycystic Ovary Syndrome, Lipid Metabolism Disorders | Phase 1 | Status: COMPLETED